iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
- Elizabeth Holt, with a proven track record of forging successful life sciences partnerships, appointed as Chief Business Officer (CBO)
- Dr Mark Velleca appointed as Board Chair, bringing considerable experience in company building and drug development
Geneva, Switzerland and Amsterdam, The Netherlands, 17 March 2025 – iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark Velleca as Chair of the Board of Directors.
